Market News

Aurora Cannabis (NASDAQ:ACB) Slides on Weak Q4

Shares of Aurora Cannabis (NASDAQ:ACB) are sliding in the pre-market session today after its fourth-quarter showing. Top-line declined 8% over the prior year to C$50.2 million.

Owing to impairment charges, net loss widened to C$618.8 million from a net loss of C$134 million in the year-ago period.

While the company’s medical vertical made modest gains, its consumer vertical witnessed a decline owing to a change in the market scenario during this period.

Looking ahead, the Street expects the company to post a net loss per share of $0.09 in Q1.  

Read full Disclosure

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More